febuxostat

... use in the treatment of hyperuricemia and quot.Febuxostat received marketing approval by the European Medicines Agency ... 2009.A study comparing febuxostat to allopurinol found that more individuals treated with febuxostat had decreased levels of uric ... 53-7Specification:99.5% HPLCAppearance: White crystalline powderDescription: Febuxostat, a novel,nonpurine,selective inhibitor of xanthine oxidase,is ...

144060-53-7 we are the manufacture, specialize in API and Intermediates. we can supply it with higher quality and competitive price, Pls take us as one of your business partner. Pls send email to us. Febuxostat

... also interested in those products,pls email us freely:1.Febuxostat & Intermediates Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5 ...